SlideShare une entreprise Scribd logo
1  sur  5
Télécharger pour lire hors ligne
Q2 FY07 Question & Answer
December 21, 2006
  1. What were some examples of major brands in the Consumer Foods segment posting sales growth for the
     quarter?

     DAVID
     Egg Beaters
     Healthy Choice
     Hebrew National
     Hunt’s
     Kid Cuisine
     Marie Callender’s
     Manwich
     Orville Redenbacher’s
     PAM
     Parkay
     Peter Pan
     Reddi-wip
     Rosarita
     Slim Jim
     Swiss Miss
     Wesson
     Wolf

  2. What were some examples of major brands in the Consumer Foods segment posting sales declines for
     the quarter?

     ACT II
     Banquet
     Blue Bonnet
     Chef Boyardee
     Knott’s Berry Farm
     LaChoy
     Libby’s
     VanCamp’s

  3. How much was total depreciation and amortization (all types) from continuing operations for the
     quarter?

     Approximately $88 million (versus approximately $74 million in Q2 2006)

  4. How much was total depreciation and amortization (all types) from continuing operations for the fiscal
     year-to-date?


                                                 Page 1 of 5
Approximately $177 million (versus $149 million through Q2 2006)

5. How much were capital expenditures from continuing operations for the quarter?

   Approximately $66 million (versus approximately $60 million in Q2 2006)

6. How much were capital expenditures from continuing operations for the fiscal year-to-date?

   Approximately $111 million (versus $120 million through Q2 2006)

7. What was the net interest expense for the quarter?

   Approximately $52 million (versus approximately $69 million in Q2 2006)

8. What was the net interest expense for the fiscal year-to-date?

   Approximately $110 million (versus approximately $141 million through Q2 2006)

9. What was corporate expense for the quarter?

   Approximately $92 million, including approximately $4 million of expense related to restructuring
   charges and a $7 million benefit resulting from a favorable franchise tax resolution (versus
   approximately $103 million in Q2 2006, including $19 million of expense related to the accelerated
   recognition of benefits in connection with the transition of certain executives)

10. How much did the company pay in dividends during the quarter?

   $92 million

11. How much did the company pay in dividends fiscal year-to-date?

   $185 million

12. What was the weighted average number of diluted shares outstanding for the quarter?

   511 million shares

13. What were the gross margins and operating margins for the quarter ($ amounts in millions, rounded)?

   Gross margin = gross profit* divided by net sales
   Gross margin = $810/$3,089 = 26.2%

   Operating margin = segment operating profit** divided by net sales
   Operating margin = $462/$3,089 = 15.0%

   * Gross profit = net sales – costs of goods sold ($3,089 – $2,279 = $810)

   **See second-quarter segment operating results for a reconciliation of operating profit to income from
   continuing operations before income taxes and equity method investment earnings (loss). Income from
   continuing operations before income taxes and equity method investment earnings (loss), divided by net
   sales = $318/$3,089 = 10.3%.

                                               Page 2 of 5
14. What is included in the company’s net debt at the end of the quarter (in millions)?

                                                   Q2 FY07              Q2 FY06
   Total debt*                                      $3,558               $4,368
   Less: Cash on hand                               $ 804                $ 687
          Net debt total                            $2,754               $3,681

   * Total debt = notes payable, short-term debt, long-term debt, and subordinated debt.

15. What is the net debt to total capital ratio at quarter end?

   37% currently and 42% a year ago

   This ratio is defined as net debt divided by the sum of net debt plus shareholder equity. See question
   #14 for the components of net debt.

16. What is the projected tax rate for continuing operations for the second half of fiscal 2007 (rounded)?

   The company plans for a tax rate of 36% on pretax earnings excluding items that impact comparability.

17. What are the projected capital expenditures for fiscal 2007?

   Approximately $450 million

18. What is the expected net interest expense for fiscal 2007?

   Approximately $225 million

19. What was the impact of adopting FAS123R during the quarter?

   Expensing of stock options resulted in recognizing increased expense of approximately $5 million
   pretax.

20. Where were the second quarter’s restructuring charges classified within Consumer Foods and
    Corporate?

   Consumer Foods:
   Cost of goods sold—approximately $17 million
   SG&A expense—approximately $11 million

   Corporate:
   SG&A expense—approximately $4 million.

21. As reported in the earnings release and prior releases, what are the main items in the second-quarter
    fiscal 2007 diluted EPS that will affect comparability with second-quarter fiscal 2006 diluted EPS?

    Summary of major items included in diluted EPS of $0.43            Second
    for the second quarter of fiscal 2007                            Quarter FY07



                                                  Page 3 of 5
Expense related to restructuring program                             $0.04
    Gain related to the sale of an oat milling operation and a non-
                                                                         $0.03
    core asset
    Benefit related to the sale of a malt joint venture                  $0.02
    Gain from a fire insurance settlement                                $0.01
    Benefit from a favorable resolution of franchise tax matters         $0.01
    Expense from net unfavorable tax settlements and changes in
                                                                         $0.02
    estimates
    Income from discontinued operations                                  $0.02

    Summary of major item included in diluted EPS of $0.29              Second
    for the second quarter of fiscal 2006                             Quarter FY06

    Impairment charges related to a joint venture                        $0.05
    Expense related to accelerated recognition of benefits in
                                                                         $0.02
    connection with transition of certain executives
    Income from discontinued operations                                  $0.07

22. Does the company have any comment on how the recent divestitures should impact SG&A cost
    reduction goals?

   The company is aggressively pursuing SG&A cost reductions, particularly focusing on costs that were
   associated with the recently divested businesses. As part of the divestiture agreements, the company is
   providing some transition services to the buyers; the company will therefore not significantly change all
   of the applicable SG&A activities or reduce the related costs until it stops providing the services. The
   buyers are reimbursing the company for these services, and the company considers the amount of the
   reimbursement to roughly represent amounts identified for cost reduction once the services and
   reimbursement have stopped. Excluding reimbursement for direct pass-through costs, buyer payment to
   ConAgra Foods during the fiscal 2007 second quarter was approximately $6 million for fixed-cost
   related items.

23. Given the changes to discontinued operations and other items in fiscal 2006 that occurred after the
    fourth quarter fiscal 2006 earnings release, what are the major items impacting EPS comparability for
    continuing operations in the second half of fiscal 2006?

Major Items Affecting Third-Quarter Fiscal 2006 EPS

Included in the $0.19 diluted EPS from Continuing Operations (EPS amounts rounded and after tax):
• Expense of $0.06 per diluted share, or $50 million pretax, for restructuring charges related to programs
   designed to reduce the company’s ongoing operating costs. These are classified as $41 million of
   expense within the Consumer Foods segment (Cost of Goods Sold of $5 million and SG&A expense of
   $36 million) and $9 million of SG&A expense within corporate.
• Expense of $0.06 per diluted share, or $47 million pretax, for a charge related to a note receivable from
   Swift and Company, which is classified as SG&A expense within corporate.
• Expense of $0.02 per diluted share, or $17 million pretax, reflecting the adjustment of a litigation
   reserve which is included within corporate.
• Benefit of $0.02 per diluted share for a lower than normal tax rate.



                                                Page 4 of 5
• Expense of $0.02 per diluted share, or $9 million pretax, resulting from asset impairment charges
  associated with an equity method investment, and classified within the results of equity method
  investment earnings (loss); this amount is not tax deductible.

Major Items Affecting Fourth-Quarter Fiscal 2006 EPS

Included in the $0.11 diluted EPS from Continuing Operations (EPS amounts rounded and after tax):
• Expense of $0.09 per diluted share, or $79 million pretax, for restructuring charges related to programs
   designed to reduce the company’s ongoing operating costs. These are classified as $44 million of
   expense within the Consumer Foods segment (Cost of Goods Sold of $15 million and SG&A expense of
   $29 million), $5 million of SG&A expense within the Food and Ingredients segment, and $30 million of
   SG&A expense within corporate.
• Expense of $0.04 per diluted share, or $36 million pretax, for a charge related to a note receivable,
   which is included within corporate.
• Expense of $0.05 per diluted share, or $24 million, resulting from asset impairment charges associated
   with an equity method investment, and classified within the results of equity method investment
   earnings (loss). There is no tax benefit related to these charges.
• Expense of $0.03 per diluted share, or $26 million pretax, for a charge related to early retirement of
   debt, which is included within corporate.
• Benefit of $0.04 per diluted share for a lower than normal tax rate.


Note on Forward-Looking Statements:
This document contains forward-looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These statements are based on management’s current views and assumptions of
future events and financial performance and are subject to uncertainty and changes in circumstances. The
company undertakes no responsibility to update these statements. Readers of this document should
understand that these statements are not guarantees of performance or results. Many factors could affect
the company’s actual financial results and cause them to vary materially from the expectations contained in
the forward-looking statements. These factors include, among other things, future economic
circumstances, industry conditions, availability and prices of raw materials, product pricing, competitive
environment and related market conditions, operating efficiencies, the company’s ability to execute its
operating and restructuring plans, access to capital, actions of governments and regulatory factors affecting
the company’s businesses and other risks described in the company’s reports filed with the Securities and
Exchange Commission. The company cautions readers not to place undue reliance on any forward-looking
statements included in this document, which speak only as of the date made.




                                               Page 5 of 5

Contenu connexe

Tendances

ConAgraFY04Q1
ConAgraFY04Q1ConAgraFY04Q1
ConAgraFY04Q1finance21
 
ameriprise 2Q06_Release
ameriprise 2Q06_Releaseameriprise 2Q06_Release
ameriprise 2Q06_Releasefinance43
 
goodrich 2Q04FinalERTotal
goodrich  2Q04FinalERTotalgoodrich  2Q04FinalERTotal
goodrich 2Q04FinalERTotalfinance44
 
ConAgra Q4Jul04
ConAgra Q4Jul04ConAgra Q4Jul04
ConAgra Q4Jul04finance21
 
ConAgra%20Foods%20Q1%20FY09%20Q&A
ConAgra%20Foods%20Q1%20FY09%20Q&AConAgra%20Foods%20Q1%20FY09%20Q&A
ConAgra%20Foods%20Q1%20FY09%20Q&Afinance21
 
raytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentationraytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentationfinance12
 
celanese q4_2008_report_e
celanese q4_2008_report_ecelanese q4_2008_report_e
celanese q4_2008_report_efinance44
 
goodrich 20041Q04E_1
goodrich  20041Q04E_1goodrich  20041Q04E_1
goodrich 20041Q04E_1finance44
 
air products & chemicals fy 08 q2 earnings
air products & chemicals fy 08 q2 earningsair products & chemicals fy 08 q2 earnings
air products & chemicals fy 08 q2 earningsfinance26
 
u.s.bancorp 1Q 2007 Earnings Release
u.s.bancorp 1Q 2007 Earnings Release u.s.bancorp 1Q 2007 Earnings Release
u.s.bancorp 1Q 2007 Earnings Release finance13
 
celanese q2_2006_presentation
celanese q2_2006_presentationcelanese q2_2006_presentation
celanese q2_2006_presentationfinance44
 
merck 4Q07 Earnings Release
merck  	4Q07 Earnings Releasemerck  	4Q07 Earnings Release
merck 4Q07 Earnings Releasefinance11
 
Q1 2009 Earning Report of International Paper Company
Q1 2009 Earning Report of International Paper CompanyQ1 2009 Earning Report of International Paper Company
Q1 2009 Earning Report of International Paper Companyearningreport earningreport
 
allstate Quarterly Investor Information 2001 4th
allstate Quarterly Investor Information 2001 4thallstate Quarterly Investor Information 2001 4th
allstate Quarterly Investor Information 2001 4thfinance7
 
goodrich YE4Q04
goodrich  YE4Q04goodrich  YE4Q04
goodrich YE4Q04finance44
 

Tendances (17)

ConAgraFY04Q1
ConAgraFY04Q1ConAgraFY04Q1
ConAgraFY04Q1
 
ameriprise 2Q06_Release
ameriprise 2Q06_Releaseameriprise 2Q06_Release
ameriprise 2Q06_Release
 
2Q_2007_PR
2Q_2007_PR2Q_2007_PR
2Q_2007_PR
 
goodrich 2Q04FinalERTotal
goodrich  2Q04FinalERTotalgoodrich  2Q04FinalERTotal
goodrich 2Q04FinalERTotal
 
ConAgra Q4Jul04
ConAgra Q4Jul04ConAgra Q4Jul04
ConAgra Q4Jul04
 
ConAgra%20Foods%20Q1%20FY09%20Q&A
ConAgra%20Foods%20Q1%20FY09%20Q&AConAgra%20Foods%20Q1%20FY09%20Q&A
ConAgra%20Foods%20Q1%20FY09%20Q&A
 
raytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentationraytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentation
 
celanese q4_2008_report_e
celanese q4_2008_report_ecelanese q4_2008_report_e
celanese q4_2008_report_e
 
goodrich 20041Q04E_1
goodrich  20041Q04E_1goodrich  20041Q04E_1
goodrich 20041Q04E_1
 
air products & chemicals fy 08 q2 earnings
air products & chemicals fy 08 q2 earningsair products & chemicals fy 08 q2 earnings
air products & chemicals fy 08 q2 earnings
 
u.s.bancorp 1Q 2007 Earnings Release
u.s.bancorp 1Q 2007 Earnings Release u.s.bancorp 1Q 2007 Earnings Release
u.s.bancorp 1Q 2007 Earnings Release
 
BlackBerry 4Q2012
BlackBerry 4Q2012BlackBerry 4Q2012
BlackBerry 4Q2012
 
celanese q2_2006_presentation
celanese q2_2006_presentationcelanese q2_2006_presentation
celanese q2_2006_presentation
 
merck 4Q07 Earnings Release
merck  	4Q07 Earnings Releasemerck  	4Q07 Earnings Release
merck 4Q07 Earnings Release
 
Q1 2009 Earning Report of International Paper Company
Q1 2009 Earning Report of International Paper CompanyQ1 2009 Earning Report of International Paper Company
Q1 2009 Earning Report of International Paper Company
 
allstate Quarterly Investor Information 2001 4th
allstate Quarterly Investor Information 2001 4thallstate Quarterly Investor Information 2001 4th
allstate Quarterly Investor Information 2001 4th
 
goodrich YE4Q04
goodrich  YE4Q04goodrich  YE4Q04
goodrich YE4Q04
 

En vedette

cmi_q407_nongaap
cmi_q407_nongaapcmi_q407_nongaap
cmi_q407_nongaapfinance21
 
williams 2005_AR
williams 2005_ARwilliams 2005_AR
williams 2005_ARfinance21
 
first energy 3Q 2007
first energy 3Q 2007first energy 3Q 2007
first energy 3Q 2007finance21
 
eaton_ar2003_noart
eaton_ar2003_noarteaton_ar2003_noart
eaton_ar2003_noartfinance21
 
first energy 4Q 06 Consolidated Report to the Financial_Community
first energy 4Q 06 Consolidated Report to the Financial_Communityfirst energy 4Q 06 Consolidated Report to the Financial_Community
first energy 4Q 06 Consolidated Report to the Financial_Communityfinance21
 
williams 3Q 2008
williams 3Q 2008williams 3Q 2008
williams 3Q 2008finance21
 

En vedette (6)

cmi_q407_nongaap
cmi_q407_nongaapcmi_q407_nongaap
cmi_q407_nongaap
 
williams 2005_AR
williams 2005_ARwilliams 2005_AR
williams 2005_AR
 
first energy 3Q 2007
first energy 3Q 2007first energy 3Q 2007
first energy 3Q 2007
 
eaton_ar2003_noart
eaton_ar2003_noarteaton_ar2003_noart
eaton_ar2003_noart
 
first energy 4Q 06 Consolidated Report to the Financial_Community
first energy 4Q 06 Consolidated Report to the Financial_Communityfirst energy 4Q 06 Consolidated Report to the Financial_Community
first energy 4Q 06 Consolidated Report to the Financial_Community
 
williams 3Q 2008
williams 3Q 2008williams 3Q 2008
williams 3Q 2008
 

Similaire à ConAgra QAFY07Q2

ConAgra QAFY06Q3
ConAgra QAFY06Q3ConAgra QAFY06Q3
ConAgra QAFY06Q3finance21
 
ConAgra Q2Dec03
ConAgra Q2Dec03ConAgra Q2Dec03
ConAgra Q2Dec03finance21
 
ConAgra QAFY06Q2
ConAgra QAFY06Q2ConAgra QAFY06Q2
ConAgra QAFY06Q2finance21
 
ConAgra Q1Sept22-04
ConAgra Q1Sept22-04ConAgra Q1Sept22-04
ConAgra Q1Sept22-04finance21
 
ConAgra Q3Mar04
ConAgra Q3Mar04ConAgra Q3Mar04
ConAgra Q3Mar04finance21
 
ConAgra Q2Dec04
ConAgra Q2Dec04ConAgra Q2Dec04
ConAgra Q2Dec04finance21
 
CIT%202Q08%20RESULTS
  CIT%202Q08%20RESULTS  CIT%202Q08%20RESULTS
CIT%202Q08%20RESULTSfinance28
 
CIT%202Q08%20RESULTS
CIT%202Q08%20RESULTSCIT%202Q08%20RESULTS
CIT%202Q08%20RESULTSfinance28
 
ameriprise Q408_Release
ameriprise Q408_Releaseameriprise Q408_Release
ameriprise Q408_Releasefinance43
 
RYDERFINAL Q406presentation
RYDERFINAL  Q406presentationRYDERFINAL  Q406presentation
RYDERFINAL Q406presentationfinance44
 
RYDERFINAL Q406presentation
RYDERFINAL Q406presentationRYDERFINAL Q406presentation
RYDERFINAL Q406presentationfinance44
 
I bytes Financial services
I bytes Financial services I bytes Financial services
I bytes Financial services EGBG Services
 
ConAgra Fiscal2008Q1_WrittenQA_Final
ConAgra Fiscal2008Q1_WrittenQA_FinalConAgra Fiscal2008Q1_WrittenQA_Final
ConAgra Fiscal2008Q1_WrittenQA_Finalfinance21
 
RYDERFINAL2Q06slides
RYDERFINAL2Q06slidesRYDERFINAL2Q06slides
RYDERFINAL2Q06slidesfinance44
 
RYDERFINAL2Q06slides
RYDERFINAL2Q06slidesRYDERFINAL2Q06slides
RYDERFINAL2Q06slidesfinance44
 
COCA-COLA ENTERPRISES Q3 2008 RESULTS
COCA-COLA ENTERPRISES Q3 2008 RESULTSCOCA-COLA ENTERPRISES Q3 2008 RESULTS
COCA-COLA ENTERPRISES Q3 2008 RESULTSearningsreport
 
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasepitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasefinance47
 
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasepitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasefinance47
 
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasepitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasefinance47
 
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes  44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasepitney bowes  44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasefinance47
 

Similaire à ConAgra QAFY07Q2 (20)

ConAgra QAFY06Q3
ConAgra QAFY06Q3ConAgra QAFY06Q3
ConAgra QAFY06Q3
 
ConAgra Q2Dec03
ConAgra Q2Dec03ConAgra Q2Dec03
ConAgra Q2Dec03
 
ConAgra QAFY06Q2
ConAgra QAFY06Q2ConAgra QAFY06Q2
ConAgra QAFY06Q2
 
ConAgra Q1Sept22-04
ConAgra Q1Sept22-04ConAgra Q1Sept22-04
ConAgra Q1Sept22-04
 
ConAgra Q3Mar04
ConAgra Q3Mar04ConAgra Q3Mar04
ConAgra Q3Mar04
 
ConAgra Q2Dec04
ConAgra Q2Dec04ConAgra Q2Dec04
ConAgra Q2Dec04
 
CIT%202Q08%20RESULTS
  CIT%202Q08%20RESULTS  CIT%202Q08%20RESULTS
CIT%202Q08%20RESULTS
 
CIT%202Q08%20RESULTS
CIT%202Q08%20RESULTSCIT%202Q08%20RESULTS
CIT%202Q08%20RESULTS
 
ameriprise Q408_Release
ameriprise Q408_Releaseameriprise Q408_Release
ameriprise Q408_Release
 
RYDERFINAL Q406presentation
RYDERFINAL  Q406presentationRYDERFINAL  Q406presentation
RYDERFINAL Q406presentation
 
RYDERFINAL Q406presentation
RYDERFINAL Q406presentationRYDERFINAL Q406presentation
RYDERFINAL Q406presentation
 
I bytes Financial services
I bytes Financial services I bytes Financial services
I bytes Financial services
 
ConAgra Fiscal2008Q1_WrittenQA_Final
ConAgra Fiscal2008Q1_WrittenQA_FinalConAgra Fiscal2008Q1_WrittenQA_Final
ConAgra Fiscal2008Q1_WrittenQA_Final
 
RYDERFINAL2Q06slides
RYDERFINAL2Q06slidesRYDERFINAL2Q06slides
RYDERFINAL2Q06slides
 
RYDERFINAL2Q06slides
RYDERFINAL2Q06slidesRYDERFINAL2Q06slides
RYDERFINAL2Q06slides
 
COCA-COLA ENTERPRISES Q3 2008 RESULTS
COCA-COLA ENTERPRISES Q3 2008 RESULTSCOCA-COLA ENTERPRISES Q3 2008 RESULTS
COCA-COLA ENTERPRISES Q3 2008 RESULTS
 
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasepitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
 
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasepitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
 
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasepitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
 
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes  44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Releasepitney bowes  44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
pitney bowes 44B330C0-AAF8-412A-8D3C-CD5D3C3E3E07_Q408_Release
 

Plus de finance21

ConAgra June92003Q&A
ConAgra June92003Q&AConAgra June92003Q&A
ConAgra June92003Q&Afinance21
 
ConAgra UAP10-03
ConAgra UAP10-03ConAgra UAP10-03
ConAgra UAP10-03finance21
 
ConAgra DealClosing11-03
ConAgra DealClosing11-03ConAgra DealClosing11-03
ConAgra DealClosing11-03finance21
 
ConAgra DealClosingb11-03
ConAgra DealClosingb11-03ConAgra DealClosingb11-03
ConAgra DealClosingb11-03finance21
 
SharePurchase12-03
SharePurchase12-03SharePurchase12-03
SharePurchase12-03finance21
 
ConAgra QAFY06Q1
ConAgra QAFY06Q1ConAgra QAFY06Q1
ConAgra QAFY06Q1finance21
 
ConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&AConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&Afinance21
 
ConAgra%20Foods%20Q2%20FY09%20Q&A
ConAgra%20Foods%20Q2%20FY09%20Q&AConAgra%20Foods%20Q2%20FY09%20Q&A
ConAgra%20Foods%20Q2%20FY09%20Q&Afinance21
 
CONAGRA Proxy 04
CONAGRA Proxy 04CONAGRA Proxy 04
CONAGRA Proxy 04finance21
 
CONAGRA 10KA-04
CONAGRA 10KA-04CONAGRA 10KA-04
CONAGRA 10KA-04finance21
 
CONAGRA 10KA-04
CONAGRA 10KA-04CONAGRA 10KA-04
CONAGRA 10KA-04finance21
 
CONAGRA Proxy 05
CONAGRA Proxy 05CONAGRA Proxy 05
CONAGRA Proxy 05finance21
 

Plus de finance21 (13)

ConAgra June92003Q&A
ConAgra June92003Q&AConAgra June92003Q&A
ConAgra June92003Q&A
 
ConAgra UAP10-03
ConAgra UAP10-03ConAgra UAP10-03
ConAgra UAP10-03
 
ConAgra DealClosing11-03
ConAgra DealClosing11-03ConAgra DealClosing11-03
ConAgra DealClosing11-03
 
ConAgra DealClosingb11-03
ConAgra DealClosingb11-03ConAgra DealClosingb11-03
ConAgra DealClosingb11-03
 
SharePurchase12-03
SharePurchase12-03SharePurchase12-03
SharePurchase12-03
 
Q3Mar05
Q3Mar05Q3Mar05
Q3Mar05
 
ConAgra QAFY06Q1
ConAgra QAFY06Q1ConAgra QAFY06Q1
ConAgra QAFY06Q1
 
ConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&AConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&A
 
ConAgra%20Foods%20Q2%20FY09%20Q&A
ConAgra%20Foods%20Q2%20FY09%20Q&AConAgra%20Foods%20Q2%20FY09%20Q&A
ConAgra%20Foods%20Q2%20FY09%20Q&A
 
CONAGRA Proxy 04
CONAGRA Proxy 04CONAGRA Proxy 04
CONAGRA Proxy 04
 
CONAGRA 10KA-04
CONAGRA 10KA-04CONAGRA 10KA-04
CONAGRA 10KA-04
 
CONAGRA 10KA-04
CONAGRA 10KA-04CONAGRA 10KA-04
CONAGRA 10KA-04
 
CONAGRA Proxy 05
CONAGRA Proxy 05CONAGRA Proxy 05
CONAGRA Proxy 05
 

Dernier

Responsible Finance Principles and Implication
Responsible Finance Principles and ImplicationResponsible Finance Principles and Implication
Responsible Finance Principles and ImplicationNghiaPham100
 
Stock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdfStock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdfMichael Silva
 
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...batoole333
 
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammam
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammamAbortion pills in Saudi Arabia (+919707899604)cytotec pills in dammam
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammamsamsungultra782445
 
Significant AI Trends for the Financial Industry in 2024 and How to Utilize Them
Significant AI Trends for the Financial Industry in 2024 and How to Utilize ThemSignificant AI Trends for the Financial Industry in 2024 and How to Utilize Them
Significant AI Trends for the Financial Industry in 2024 and How to Utilize Them360factors
 
劳伦森大学毕业证
劳伦森大学毕业证劳伦森大学毕业证
劳伦森大学毕业证yyawb
 
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...kajalverma014
 
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.hyt3577
 
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...Health
 
Explore Dual Citizenship in Africa | Citizenship Benefits & Requirements
Explore Dual Citizenship in Africa | Citizenship Benefits & RequirementsExplore Dual Citizenship in Africa | Citizenship Benefits & Requirements
Explore Dual Citizenship in Africa | Citizenship Benefits & Requirementsmarketingkingdomofku
 
In Sharjah ௵(+971)558539980 *_௵abortion pills now available.
In Sharjah ௵(+971)558539980 *_௵abortion pills now available.In Sharjah ௵(+971)558539980 *_௵abortion pills now available.
In Sharjah ௵(+971)558539980 *_௵abortion pills now available.hyt3577
 
Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...robinsonayot
 
cost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptxcost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptxazadalisthp2020i
 
Lion One Corporate Presentation May 2024
Lion One Corporate Presentation May 2024Lion One Corporate Presentation May 2024
Lion One Corporate Presentation May 2024Adnet Communications
 
Mahendragarh Escorts 🥰 8617370543 Call Girls Offer VIP Hot Girls
Mahendragarh Escorts 🥰 8617370543 Call Girls Offer VIP Hot GirlsMahendragarh Escorts 🥰 8617370543 Call Girls Offer VIP Hot Girls
Mahendragarh Escorts 🥰 8617370543 Call Girls Offer VIP Hot GirlsDeepika Singh
 
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdf
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdfMASTERING FOREX: STRATEGIES FOR SUCCESS.pdf
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdfCocity Enterprises
 
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai MultipleDubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiplekojalpk89
 
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadh
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadhabortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadh
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadhsamsungultra782445
 
Toronto dominion bank investor presentation.pdf
Toronto dominion bank investor presentation.pdfToronto dominion bank investor presentation.pdf
Toronto dominion bank investor presentation.pdfJinJiang6
 

Dernier (20)

Responsible Finance Principles and Implication
Responsible Finance Principles and ImplicationResponsible Finance Principles and Implication
Responsible Finance Principles and Implication
 
Stock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdfStock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdf
 
W.D. Gann Theory Complete Information.pdf
W.D. Gann Theory Complete Information.pdfW.D. Gann Theory Complete Information.pdf
W.D. Gann Theory Complete Information.pdf
 
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
 
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammam
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammamAbortion pills in Saudi Arabia (+919707899604)cytotec pills in dammam
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammam
 
Significant AI Trends for the Financial Industry in 2024 and How to Utilize Them
Significant AI Trends for the Financial Industry in 2024 and How to Utilize ThemSignificant AI Trends for the Financial Industry in 2024 and How to Utilize Them
Significant AI Trends for the Financial Industry in 2024 and How to Utilize Them
 
劳伦森大学毕业证
劳伦森大学毕业证劳伦森大学毕业证
劳伦森大学毕业证
 
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...
 
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.
 
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
 
Explore Dual Citizenship in Africa | Citizenship Benefits & Requirements
Explore Dual Citizenship in Africa | Citizenship Benefits & RequirementsExplore Dual Citizenship in Africa | Citizenship Benefits & Requirements
Explore Dual Citizenship in Africa | Citizenship Benefits & Requirements
 
In Sharjah ௵(+971)558539980 *_௵abortion pills now available.
In Sharjah ௵(+971)558539980 *_௵abortion pills now available.In Sharjah ௵(+971)558539980 *_௵abortion pills now available.
In Sharjah ௵(+971)558539980 *_௵abortion pills now available.
 
Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...
 
cost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptxcost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptx
 
Lion One Corporate Presentation May 2024
Lion One Corporate Presentation May 2024Lion One Corporate Presentation May 2024
Lion One Corporate Presentation May 2024
 
Mahendragarh Escorts 🥰 8617370543 Call Girls Offer VIP Hot Girls
Mahendragarh Escorts 🥰 8617370543 Call Girls Offer VIP Hot GirlsMahendragarh Escorts 🥰 8617370543 Call Girls Offer VIP Hot Girls
Mahendragarh Escorts 🥰 8617370543 Call Girls Offer VIP Hot Girls
 
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdf
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdfMASTERING FOREX: STRATEGIES FOR SUCCESS.pdf
MASTERING FOREX: STRATEGIES FOR SUCCESS.pdf
 
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai MultipleDubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
 
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadh
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadhabortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadh
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadh
 
Toronto dominion bank investor presentation.pdf
Toronto dominion bank investor presentation.pdfToronto dominion bank investor presentation.pdf
Toronto dominion bank investor presentation.pdf
 

ConAgra QAFY07Q2

  • 1. Q2 FY07 Question & Answer December 21, 2006 1. What were some examples of major brands in the Consumer Foods segment posting sales growth for the quarter? DAVID Egg Beaters Healthy Choice Hebrew National Hunt’s Kid Cuisine Marie Callender’s Manwich Orville Redenbacher’s PAM Parkay Peter Pan Reddi-wip Rosarita Slim Jim Swiss Miss Wesson Wolf 2. What were some examples of major brands in the Consumer Foods segment posting sales declines for the quarter? ACT II Banquet Blue Bonnet Chef Boyardee Knott’s Berry Farm LaChoy Libby’s VanCamp’s 3. How much was total depreciation and amortization (all types) from continuing operations for the quarter? Approximately $88 million (versus approximately $74 million in Q2 2006) 4. How much was total depreciation and amortization (all types) from continuing operations for the fiscal year-to-date? Page 1 of 5
  • 2. Approximately $177 million (versus $149 million through Q2 2006) 5. How much were capital expenditures from continuing operations for the quarter? Approximately $66 million (versus approximately $60 million in Q2 2006) 6. How much were capital expenditures from continuing operations for the fiscal year-to-date? Approximately $111 million (versus $120 million through Q2 2006) 7. What was the net interest expense for the quarter? Approximately $52 million (versus approximately $69 million in Q2 2006) 8. What was the net interest expense for the fiscal year-to-date? Approximately $110 million (versus approximately $141 million through Q2 2006) 9. What was corporate expense for the quarter? Approximately $92 million, including approximately $4 million of expense related to restructuring charges and a $7 million benefit resulting from a favorable franchise tax resolution (versus approximately $103 million in Q2 2006, including $19 million of expense related to the accelerated recognition of benefits in connection with the transition of certain executives) 10. How much did the company pay in dividends during the quarter? $92 million 11. How much did the company pay in dividends fiscal year-to-date? $185 million 12. What was the weighted average number of diluted shares outstanding for the quarter? 511 million shares 13. What were the gross margins and operating margins for the quarter ($ amounts in millions, rounded)? Gross margin = gross profit* divided by net sales Gross margin = $810/$3,089 = 26.2% Operating margin = segment operating profit** divided by net sales Operating margin = $462/$3,089 = 15.0% * Gross profit = net sales – costs of goods sold ($3,089 – $2,279 = $810) **See second-quarter segment operating results for a reconciliation of operating profit to income from continuing operations before income taxes and equity method investment earnings (loss). Income from continuing operations before income taxes and equity method investment earnings (loss), divided by net sales = $318/$3,089 = 10.3%. Page 2 of 5
  • 3. 14. What is included in the company’s net debt at the end of the quarter (in millions)? Q2 FY07 Q2 FY06 Total debt* $3,558 $4,368 Less: Cash on hand $ 804 $ 687 Net debt total $2,754 $3,681 * Total debt = notes payable, short-term debt, long-term debt, and subordinated debt. 15. What is the net debt to total capital ratio at quarter end? 37% currently and 42% a year ago This ratio is defined as net debt divided by the sum of net debt plus shareholder equity. See question #14 for the components of net debt. 16. What is the projected tax rate for continuing operations for the second half of fiscal 2007 (rounded)? The company plans for a tax rate of 36% on pretax earnings excluding items that impact comparability. 17. What are the projected capital expenditures for fiscal 2007? Approximately $450 million 18. What is the expected net interest expense for fiscal 2007? Approximately $225 million 19. What was the impact of adopting FAS123R during the quarter? Expensing of stock options resulted in recognizing increased expense of approximately $5 million pretax. 20. Where were the second quarter’s restructuring charges classified within Consumer Foods and Corporate? Consumer Foods: Cost of goods sold—approximately $17 million SG&A expense—approximately $11 million Corporate: SG&A expense—approximately $4 million. 21. As reported in the earnings release and prior releases, what are the main items in the second-quarter fiscal 2007 diluted EPS that will affect comparability with second-quarter fiscal 2006 diluted EPS? Summary of major items included in diluted EPS of $0.43 Second for the second quarter of fiscal 2007 Quarter FY07 Page 3 of 5
  • 4. Expense related to restructuring program $0.04 Gain related to the sale of an oat milling operation and a non- $0.03 core asset Benefit related to the sale of a malt joint venture $0.02 Gain from a fire insurance settlement $0.01 Benefit from a favorable resolution of franchise tax matters $0.01 Expense from net unfavorable tax settlements and changes in $0.02 estimates Income from discontinued operations $0.02 Summary of major item included in diluted EPS of $0.29 Second for the second quarter of fiscal 2006 Quarter FY06 Impairment charges related to a joint venture $0.05 Expense related to accelerated recognition of benefits in $0.02 connection with transition of certain executives Income from discontinued operations $0.07 22. Does the company have any comment on how the recent divestitures should impact SG&A cost reduction goals? The company is aggressively pursuing SG&A cost reductions, particularly focusing on costs that were associated with the recently divested businesses. As part of the divestiture agreements, the company is providing some transition services to the buyers; the company will therefore not significantly change all of the applicable SG&A activities or reduce the related costs until it stops providing the services. The buyers are reimbursing the company for these services, and the company considers the amount of the reimbursement to roughly represent amounts identified for cost reduction once the services and reimbursement have stopped. Excluding reimbursement for direct pass-through costs, buyer payment to ConAgra Foods during the fiscal 2007 second quarter was approximately $6 million for fixed-cost related items. 23. Given the changes to discontinued operations and other items in fiscal 2006 that occurred after the fourth quarter fiscal 2006 earnings release, what are the major items impacting EPS comparability for continuing operations in the second half of fiscal 2006? Major Items Affecting Third-Quarter Fiscal 2006 EPS Included in the $0.19 diluted EPS from Continuing Operations (EPS amounts rounded and after tax): • Expense of $0.06 per diluted share, or $50 million pretax, for restructuring charges related to programs designed to reduce the company’s ongoing operating costs. These are classified as $41 million of expense within the Consumer Foods segment (Cost of Goods Sold of $5 million and SG&A expense of $36 million) and $9 million of SG&A expense within corporate. • Expense of $0.06 per diluted share, or $47 million pretax, for a charge related to a note receivable from Swift and Company, which is classified as SG&A expense within corporate. • Expense of $0.02 per diluted share, or $17 million pretax, reflecting the adjustment of a litigation reserve which is included within corporate. • Benefit of $0.02 per diluted share for a lower than normal tax rate. Page 4 of 5
  • 5. • Expense of $0.02 per diluted share, or $9 million pretax, resulting from asset impairment charges associated with an equity method investment, and classified within the results of equity method investment earnings (loss); this amount is not tax deductible. Major Items Affecting Fourth-Quarter Fiscal 2006 EPS Included in the $0.11 diluted EPS from Continuing Operations (EPS amounts rounded and after tax): • Expense of $0.09 per diluted share, or $79 million pretax, for restructuring charges related to programs designed to reduce the company’s ongoing operating costs. These are classified as $44 million of expense within the Consumer Foods segment (Cost of Goods Sold of $15 million and SG&A expense of $29 million), $5 million of SG&A expense within the Food and Ingredients segment, and $30 million of SG&A expense within corporate. • Expense of $0.04 per diluted share, or $36 million pretax, for a charge related to a note receivable, which is included within corporate. • Expense of $0.05 per diluted share, or $24 million, resulting from asset impairment charges associated with an equity method investment, and classified within the results of equity method investment earnings (loss). There is no tax benefit related to these charges. • Expense of $0.03 per diluted share, or $26 million pretax, for a charge related to early retirement of debt, which is included within corporate. • Benefit of $0.04 per diluted share for a lower than normal tax rate. Note on Forward-Looking Statements: This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s current views and assumptions of future events and financial performance and are subject to uncertainty and changes in circumstances. The company undertakes no responsibility to update these statements. Readers of this document should understand that these statements are not guarantees of performance or results. Many factors could affect the company’s actual financial results and cause them to vary materially from the expectations contained in the forward-looking statements. These factors include, among other things, future economic circumstances, industry conditions, availability and prices of raw materials, product pricing, competitive environment and related market conditions, operating efficiencies, the company’s ability to execute its operating and restructuring plans, access to capital, actions of governments and regulatory factors affecting the company’s businesses and other risks described in the company’s reports filed with the Securities and Exchange Commission. The company cautions readers not to place undue reliance on any forward-looking statements included in this document, which speak only as of the date made. Page 5 of 5